CN111944529B - 碳酸氢钠注射液包装用碳酸氢钠缓释片 - Google Patents
碳酸氢钠注射液包装用碳酸氢钠缓释片 Download PDFInfo
- Publication number
- CN111944529B CN111944529B CN202010864823.4A CN202010864823A CN111944529B CN 111944529 B CN111944529 B CN 111944529B CN 202010864823 A CN202010864823 A CN 202010864823A CN 111944529 B CN111944529 B CN 111944529B
- Authority
- CN
- China
- Prior art keywords
- sodium bicarbonate
- parts
- packaging
- release tablet
- slow release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 title claims abstract description 241
- 229910000030 sodium bicarbonate Inorganic materials 0.000 title claims abstract description 121
- 235000017557 sodium bicarbonate Nutrition 0.000 title claims abstract description 121
- 238000002347 injection Methods 0.000 title claims abstract description 42
- 239000007924 injection Substances 0.000 title claims abstract description 42
- 238000004806 packaging method and process Methods 0.000 title claims abstract description 28
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 32
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 32
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 32
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract description 13
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract description 13
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 13
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract description 13
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract description 13
- 239000001069 triethyl citrate Substances 0.000 claims abstract description 13
- 235000013769 triethyl citrate Nutrition 0.000 claims abstract description 13
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000005469 granulation Methods 0.000 claims description 13
- 230000003179 granulation Effects 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000008215 water for injection Substances 0.000 claims description 5
- 229960003943 hypromellose Drugs 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 2
- 239000007939 sustained release tablet Substances 0.000 abstract description 18
- 239000003826 tablet Substances 0.000 abstract description 17
- 239000007787 solid Substances 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 231100000989 no adverse effect Toxicity 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 32
- 239000001569 carbon dioxide Substances 0.000 description 16
- 229910002092 carbon dioxide Inorganic materials 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 13
- 239000011521 glass Substances 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229910001868 water Inorganic materials 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000007935 oral tablet Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 241001411320 Eriogonum inflatum Species 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- -1 compound sodium bicarbonate Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000009512 pharmaceutical packaging Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/02—Anti-oxidant compositions; Compositions inhibiting chemical change containing inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
- B65D81/20—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
- B65D81/2069—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
- B65D81/2084—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere in a flexible container
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/50—Carbon dioxide
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
- C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
包装名称 | 0月 | 加速1月 | 加速2月 | 加速3月 | 加速6月 |
实验例1 | 99.85% | 99.80% | 99.82% | 99.84% | 99.85% |
比较例1 | 99.85% | 99.84% | 99.80% | 99.26% | 98.77% |
比较例2 | 99.85% | 99.84% | 99.80% | 99.30% | 98.83% |
比较例3 | 99.85% | 100.04% | 100.53% | 99.98% | 99.86% |
包装名称 | 0月 | 加速1月 | 加速2月 | 加速3月 | 加速6月 |
实验例1 | 13.2% | 13.2% | 13.2% | 13.4% | 13.3% |
比较例1 | 13.3% | 12.7% | 12.3% | 12.1% | 11.9% |
比较例2 | 13.2% | 12.8% | 12.2% | 12.1% | 12.0% |
比较例3 | 13.3% | 13.9% | 14.2% | 15.1% | 13.8% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010864823.4A CN111944529B (zh) | 2020-08-25 | 2020-08-25 | 碳酸氢钠注射液包装用碳酸氢钠缓释片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010864823.4A CN111944529B (zh) | 2020-08-25 | 2020-08-25 | 碳酸氢钠注射液包装用碳酸氢钠缓释片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111944529A CN111944529A (zh) | 2020-11-17 |
CN111944529B true CN111944529B (zh) | 2021-09-14 |
Family
ID=73366354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010864823.4A Active CN111944529B (zh) | 2020-08-25 | 2020-08-25 | 碳酸氢钠注射液包装用碳酸氢钠缓释片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111944529B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682719A (zh) * | 2005-03-01 | 2005-10-19 | 沈阳药科大学 | 一种含有石杉碱甲的肠溶包衣缓释片剂及制备方法 |
CN101618770A (zh) * | 2009-08-17 | 2010-01-06 | 湖南千山制药机械股份有限公司 | 一种碳酸氢钠注射液的包装方法 |
CN202366163U (zh) * | 2011-11-22 | 2012-08-08 | 四川科伦药物研究有限公司 | 一种碳酸氢钠注射液塑料瓶包装 |
CN104107140A (zh) * | 2014-06-23 | 2014-10-22 | 武汉药谷生物工程有限公司 | 用于含有碳酸氢钠的注射液的软包装 |
CN104739819A (zh) * | 2007-11-09 | 2015-07-01 | 田边三菱制药株式会社 | 新型制剂 |
CN105540009A (zh) * | 2014-11-03 | 2016-05-04 | 南宁市黑晶信息技术有限公司 | 一种碳酸氢钠注射液塑料软袋包装 |
CN107648258A (zh) * | 2017-11-24 | 2018-02-02 | 安徽金阳光农业服务有限公司 | 复方碳酸氢钠片及其制备方法 |
-
2020
- 2020-08-25 CN CN202010864823.4A patent/CN111944529B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682719A (zh) * | 2005-03-01 | 2005-10-19 | 沈阳药科大学 | 一种含有石杉碱甲的肠溶包衣缓释片剂及制备方法 |
CN104739819A (zh) * | 2007-11-09 | 2015-07-01 | 田边三菱制药株式会社 | 新型制剂 |
CN101618770A (zh) * | 2009-08-17 | 2010-01-06 | 湖南千山制药机械股份有限公司 | 一种碳酸氢钠注射液的包装方法 |
CN202366163U (zh) * | 2011-11-22 | 2012-08-08 | 四川科伦药物研究有限公司 | 一种碳酸氢钠注射液塑料瓶包装 |
CN104107140A (zh) * | 2014-06-23 | 2014-10-22 | 武汉药谷生物工程有限公司 | 用于含有碳酸氢钠的注射液的软包装 |
CN105540009A (zh) * | 2014-11-03 | 2016-05-04 | 南宁市黑晶信息技术有限公司 | 一种碳酸氢钠注射液塑料软袋包装 |
CN107648258A (zh) * | 2017-11-24 | 2018-02-02 | 安徽金阳光农业服务有限公司 | 复方碳酸氢钠片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111944529A (zh) | 2020-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3171868B1 (en) | Packaged acetaminophen injection solution preparation | |
US20040054012A1 (en) | Method for obtaining aqueous formulations of oxidation-sensitive active principles | |
CN102579386A (zh) | 一种稳定的奥拉西坦制剂 | |
EP3281625B1 (en) | Oral film preparation | |
UA97108C2 (uk) | Застосування поліолів для отримання стабільних поліморфних форм рифаксиміну | |
TWI808349B (zh) | 含有芳基烷基胺化合物之醫藥組合物 | |
CN111944529B (zh) | 碳酸氢钠注射液包装用碳酸氢钠缓释片 | |
JP3243387B2 (ja) | 炭酸水素塩含有薬液入りプラスチック容器の収納体 | |
JP6741286B2 (ja) | 包装されたアセトアミノフェン注射液製剤の製造方法 | |
KR102246136B1 (ko) | 산화-민감성 제형을 위한 안정한 즉석 사용식 주입 백을 제조하는 방법 | |
JP2013010753A (ja) | 糖衣製剤及びその製造方法 | |
US9481652B2 (en) | Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof | |
RU2686694C2 (ru) | Комбинированный лекарственный препарат в форме шипучих таблеток и способ его получения | |
JP5280420B2 (ja) | ナフトピジルを含有する医薬の製造方法 | |
JP2009227658A (ja) | アカルボースを含有する錠剤 | |
EP2117534B1 (en) | A pharmaceutical composition with atorvastatin active ingredient | |
JP5208348B2 (ja) | ナフトピジルを含有する医薬 | |
JP4993246B2 (ja) | 経時的安定性に優れたアカルボース含有錠剤の製剤化方法 | |
JP6461496B2 (ja) | 解熱鎮痛製剤 | |
AU2018255376A1 (en) | Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDS, and a composition obtained thereof | |
JPS62194861A (ja) | 液状医薬品包装体 | |
CN101549159B (zh) | 羟丙基-β-环糊精在氯霉素滴眼剂中的应用及方法 | |
CN118178409A (zh) | 一种艾沙康唑药物组合物及其制备方法 | |
JP2021134214A (ja) | 固形組成物 | |
JP2016079120A (ja) | 包装により安定性が改善されたオランザピン製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230927 Address after: 430000 No. a5-2, building 1, Wuhan Optical Valley International Biomedical enterprise accelerator, No. 388, Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee after: LONGLY BIOTECHNOLOGY (WUHAN) Co.,Ltd. Address before: 430000 east third floor, building A05, bio Park Road pharmaceutical Park, No. 858, Gaoxin Avenue, Donghu high tech Zone, Wuhan, Hubei Patentee before: WUHAN YAOGU BIOLOGICAL ENGINEERING CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231012 Address after: 430000, 3rd Floor, East Side, Building A2-2, Accelerator Phase I, Biopharmaceutical Industrial Park, No. 858 Gaoxin Avenue, Donghu High tech Zone, Wuhan, Hubei Province Patentee after: WUHAN YAOGU BIOLOGICAL ENGINEERING CO.,LTD. Address before: 430000 No. a5-2, building 1, Wuhan Optical Valley International Biomedical enterprise accelerator, No. 388, Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee before: LONGLY BIOTECHNOLOGY (WUHAN) Co.,Ltd. |